CML articles & resources on Made-in-China.com

Carlsberg to Sell Stake in Malawi Business to Castel Group

Aug 15, 2016

Carlsberg Group has signed an agreement to sell 59% of its share in Carlsberg Malawi Limited to Castel Group. The registration of the transaction is pending certain regulatory and corporate approvals. The transaction is in line with ...

Tags: Carlsberg Group, agreement, Malawi

Ageing Infrastructure Is a Major Problem for Almost Every Power Utility

Dec 19, 2013

Ageing infrastructure is a major problem for almost every power utility in the developed world, and it's a problem that becomes particularly acute when the original manufacturer gives notice that support will soon be withdrawn for an asset ...

Tags: ageing infrastructure, power utility

Study Respondents Consider Crewing The Most Challenging Area Over The Medium Term

Aug 5, 2013

GL shares best practice in ship management study results Monday, Aug 05, 2013 Germanischer Lloyd (GL) will introduce the results of a joint global study on 'Best Practice in Ship Management', conducted with the Fraunhofer Center for ...

Tags: Transportation, customs, Ship Management

The UK NICE Has Rejected Pfizer's New Chronic Myeloid Leukaemia (CML) Drug

Jul 17, 2013

The UK National Institute for Health and Care Excellence (NICE) has rejected Pfizer’s new chronic myeloid leukaemia (CML) drug, Bosulif (bosutinib). NICE chief executive Sir Andrew Dillon said there is evidence to suggest that ...

Tags: Cancer Drug, Medicine

Doctors Calls for Lower Cancer Patients' Drugs Price

May 6, 2013

If you've ever had trouble affording your medications and wanted to call your doctor on it, here's some encouraging news: Doctors aren't pleased about the prices either. Denouncing "profiteering" by pharmaceutical companies, more than 100 ...

Tags: Drug, Health, Medicine

CML Healthcare Installs Bd's Automated Microbiology Systems at Its Central Laboratory

Apr 11, 2013

CML HealthCare, a Canada-based provider of medical diagnostic services, has entered into an agreement to install BD's automated microbiology systems at its central laboratory. The installation of Kiestra Total Laboratory Automation (TLA) ...

Tags: CML HealthCare, BD Automated Microbiology Systems

EC Granted Conditional Marketing Authorization for Bosutinib Anti-Cancer Drug in The EC

Apr 1, 2013

The European Commission (EC) has granted conditional marketing authorization for Pfizer's Bosulif (bosutinib) anti-cancer drug in the European Union (EU). Bosulif is authorized in Europe for the treatment of adult patients with chronic ...

Tags: Pfizer Bosulif, cancer drug, drug

Labceutics Has Signed a Agreement with Asuragen to Conduct a Quality Assurance Study

Mar 14, 2013

Labceutics has signed a agreement with Asuragen to conduct an international multi-center quality assurance study on the standardization of BCR-ABL1 quantitative measurements on the International Scale (IS). Participating laboratories ...

Tags: Labceutics, Asuragen, Conduct Pan European Study, CML

Sysmex Hematology Automation Systems Will Be Deployed by CML Soon

Feb 19, 2013

Canada-based CML HealthCare has signed a vendor supply and capital equipment service agreement with Sysmex's Canadian subsidiary Sysmex Canada. As per the agreement, CML will buy three Sysmex HST-N total hematology automation systems and ...

Tags: CML HealthCare, capital equipment service agreement, Sysmex

Pfizer's Bosutinib Received Positive Opinion for The Conditional Marketing Authorization

Jan 22, 2013

Pfizer's bosutinib has received positive opinion for the conditional marketing authorization from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP). The bosutinib positive CHMP opinion is concerned with ...

Tags: Medicines, CHMP, medical

Mitomics Prostate Core Mitomic Test Will Be Provided by Cml Healthcare in Canada

Dec 18, 2012

Medical diagnostic services provider CML HealthCare has entered into a license agreement to provide Mitomics' Prostate Core Mitomic test (PCMT) to urologists across Canada. Using the science of mitochondrial DNA analysis, the test ...

Tags: license agreement, clinical trial, medical technology

Ariad Pharmaceuticals Submitted NDA for Its Investigational BCR-ABL Inhibitor

Dec 7, 2012

US based Ariad Pharmaceuticals has submitted New Drug Application (NDA) for its investigational BCR-ABL inhibitor, ponatinib for the approval of US Food and Drug Administration (FDA). Ponatinib is indicated for patients with resistant or ...

Tags: BCR-ABL inhibitor, CML, Ph+ALL

FDA Approved Pfizer's Bosulf to Treat Adult Patients with PH+ CML

Dec 5, 2012

US Food and Drug Administration (FDA) has approved Pfizer's Bosulf (bosutinib) to treat adult patients with chronic, accelerated or blast phase Philadelphia chromosome-positive (Ph+) (CML) with resistance to prior therapy. Bosulif is a ...

Tags: bosulf, bosutinib, kinase inhibitor, Philadelphia chromosome-positive

Teva Pharmaceutical Received US FDA Approval for Synribo Injection

Nov 28, 2012

Teva Pharmaceutical has received US Food and Drug Administration(FDA)approval for Synribo injection to treat adult patients with chronic phase(CP)or accelerated phase(AP)chronic myeloid leukemia(CML)with resistance and/or intolerance to ...

Tags: Teva Synribo Injection, US FDA, Teva Pharmaceutical, chronic phase

DOE Has Announced The Completion of The Series 18 Testing of a Group of 17 LED

Nov 2, 2012

The US Department of Energy (DOE) has announced the completion of the Series 18 testing of a group of 17 LED recessed wallwasher luminaires. The results indicate that, while some LED recessed wallwashers are already competitive with ...

Tags: LED wallwasher

CML

Related Products